SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-111145
Filing Date
2021-08-31
Accepted
2021-08-30 18:04:29
Documents
12
Period of Report
2021-08-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2126615d1_8k.htm   iXBRL 8-K 24512
  Complete submission text file 0001104659-21-111145.txt   200524

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cara-20210830.xsd EX-101.SCH 3212
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20210830_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20210830_pre.xml EX-101.PRE 22728
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2126615d1_8k_htm.xml XML 3733
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 211224788
SIC: 2834 Pharmaceutical Preparations